Adequate funding is essential for sustained innovation in cancer research. Grants from organizations like the National Cancer Institute and private foundations enable researchers to pursue groundbreaking studies. Increased investment in early-stage research can lead to the discovery of novel biomarkers and therapeutic targets, while funding for clinical trials ensures that new treatments are rigorously tested for safety and efficacy.
